System Transmission

Top Signal

100#1 JOB

Activity

2163Ripe

+917 today

System

Livenow

Terminal Asset View

stockNASDAQ

ESPR

$2.44-1.21%

Esperion Therapeutics Inc

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

14Neutral

Live Analysis Active

Company Mission

Esperion Therapeutics develops and sells prescription medications that help lower cholesterol levels in people with cardiovascular disease. Their drugs are prescribed by doctors and dispensed through pharmacies to patients who need cholesterol management. The company makes money by selling these medications to healthcare systems, pharmacies, and through partnerships with larger pharmaceutical companies.

ESP

Industry Context

Esperion operates in the biotechnology and pharmaceutical industry, which focuses on developing new medicines and treatments. This industry is highly regulated and depends on successful clinical trials and government approvals for new drugs. Companies in this space often have volatile stock prices as investors react to trial results and regulatory decisions.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

36Matrix

Market Momentum

29.4— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.2x— Normal Volume

Today's Change

-1.21%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-1

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing ESPR across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 07:25 PM UTC

As-of 03-14-2026 19:10 UTC

Develops cholesterol-lowering pills and makes money by selling these prescription drugs to pharmacies and hospitals.

Weekly volatility is tightening near recent lows, suggesting the stock may be preparing for a larger move in either direction showing consolidation.

Biotech sector faces regulatory uncertainty, which could impact drug approval timelines and investor sentiment toward development-stage companies.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...